
Oncology NEWS International
- Oncology NEWS International Vol 7 No 3
- Volume 7
- Issue 3
Universities Receive $100 Million for Biomedical Research
LOS ANGELES--California businessman Alfred E. Mann has donated $100 million each to the University of Southern California (USC) and the University of California at Los Angeles (UCLA) to set up institutes for biomedical research.
LOS ANGELES--California businessman Alfred E. Mann has donated $100 million each to the University of Southern California (USC) and the University of California at Los Angeles (UCLA) to set up institutes for biomedical research.
At USC, the Alfred E. Mann Institute for Biomedical Engineering will be based on the Universitys campus in a building that will also house the Department of Biomedical Engineering. USC president Dr. Steven Sample said that the institute would serve as a bridge between the university and the biomedical industry. Mr. Mann said he hopes the new institutes will encourage development of biotechnology companies in the Los Angeles area.
The gift to UCLA is one of the largest donations ever to a public university. The agreement for the UCLA institute is still being developed.
Articles in this issue
almost 28 years ago
ACS Takes Aim at Proposed Federal Tobacco Billsalmost 28 years ago
Loan Defaults Disqualify 1,402almost 28 years ago
FDA Gives OK to Seven New Cancer Drugs in 1997almost 28 years ago
HIA Chemo Promising in Colon Cancer Liver Metsalmost 28 years ago
Proposed Budget Spells ‘Good News’ for NCIalmost 28 years ago
Proposed Budget Has Extra Funds for FDA Teen Smoking Effortalmost 28 years ago
CRFA Awards 16 New Grants and Fellowshipsalmost 28 years ago
Cancer Pain Treatment Requires Clear Terminology About ‘Addiction’almost 28 years ago
‘Staging’ of the Managed Care Market Is Crucialalmost 28 years ago
NCI, EPA Attempt to Resolve Differences Over Childhood CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
















































































